Imatinib mesylate inhibits the growth of metastatic lung lesions in a patient with dermatofibrosarcoma protuberans
- 29 June 2004
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 151 (1) , 235-237
- https://doi.org/10.1111/j.1365-2133.2004.06024.x
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Analysis of gene mutations in three cases of dermatofibrosarcoma protuberans (DFSP): ordinary DFSP, DFSP with fibrosarcomatous lesion (DFSP-FS) and lung metastasis of DFSP-FSJournal of Dermatological Science, 2003
- Molecular Targeting of Platelet-Derived Growth Factor B by Imatinib Mesylate in a Patient With Metastatic Dermatofibrosarcoma ProtuberansJournal of Clinical Oncology, 2002
- Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberansInternational Journal of Cancer, 2002
- Fibrosarcomatous ("High-Grade") Dermatofibrosarcoma ProtuberansThe American Journal of Surgical Pathology, 1998
- Deregulation of the platelet-derived growth factor β-chain gene via fusion with collagen gene COL1A1 in dermatof ibrosarcoma protuberans and giant-cell fibroblastomaNature Genetics, 1997
- Translocation, t(17;22)(q22;q13), in dermatofibrosarcoma protuberans: a new tumor-associated chromosome rearrangementCytogenetic and Genome Research, 1996